… have been directly used on COVID-19 patients on ‘trial and … four-classes of potential
therapeutic options, including the … , to prevent the onset of COVID-19. The ACE2 receptors in the …

… This review has summarized the current state of COVID-19 therapeutic management based
on available clinical trials and guidelines as of October 2021. While an extensive amount of …

… This meta-analysis aimed at evaluating the efficacy and safety of current option … COVID-19,
in an attempt to identify promising therapy for severe acute respiratory syndrome coronavirus …

… We have provided detailed information on available therapeutic options, which have
proved to be effective in improving clinical symptoms of severe COVID-19 patients. …

… Therapeutic options for coronavirus disease 2019 are desperately needed to respond to
the ongoing severe acute respiratory syndrome coronavirus … of coronavirus disease 2019. …

… in the positive patients as well as suspects of COVID-19. In-vitro studies are also carried out
… options and discussing their efficacy and effectiveness in the treatment of COVID-19. Also, …

… observed in patients with severe COVID-19 remains poorly understood. The pharmacological
targeting of complement activation in severe COVID-19 may attenuate the increased …

… WHO has declared COVID-19 a worldwide pandemic and Europe as a new epicenter of
COVID-19 … Despite such preventive measures, there is no recommended drug therapy officially …

Since December 2019, China has been experiencing an outbreak of COVID-19, caused by
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). This disease has spread …

… and therapeutic similarities of COVID-19 patients and … therapeutic challenges associated
with autoimmune diseases and their use in controlling the clinical condition of COVID-19 …